| Stage | MRCY | % of rev | CWST | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $290M | 100.00% | $544M | 100.00% | CWST ×1.88 |
| Gross profit | $89M | 30.57% | $179M | 32.88% | CWST +2.3pp |
| Operating income | $14M | 4.99% | $20M | 3.67% | MRCY +1.3pp |
| Pre-tax income | $8M | 2.69% | $3M | 0.62% | MRCY +2.1pp |
| Net income | $798,000 | 0.28% | $4M | 0.69% | CWST +0.4pp |
| Stage | MRCY | CWST | Gap · A − B |
|---|---|---|---|
| Revenue | $290M100.00% | $544M100.00% | CWST ×1.88 |
| Gross profit | 30.57%$89M | 32.88%$179M | CWST +2.3pp |
| Operating income | 4.99%$14M | 3.67%$20M | MRCY +1.3pp |
| Pre-tax income | 2.69%$8M | 0.62%$3M | MRCY +2.1pp |
| Net income |
| 0.28%$798,000 |
| 0.69%$4M |
| CWST +0.4pp |
No shared counterparties.